Airsupra (albuterol/budesonide) made history in 2023 as the first FDA-approved rescue inhaler that combines a fast-acting bronchodilator with an anti-inflammatory corticosteroid in a single device. For asthma patients, that’s a meaningful clinical advance. For their wallets, the Airsupra inhaler cost raises familiar questions about brand-name drug pricing. Without insurance, expect to pay between $250 and $400 — a steep jump from the $20-$50 range for generic albuterol alone. Here’s what drives that price and how to bring it down.
Airsupra Retail Price Without Insurance
A single Airsupra inhaler (180 mcg albuterol/160 mcg budesonide per actuation, approximately 180 metered doses) typically costs:
- Chain pharmacies (CVS, Walgreens, Rite Aid): $350 to $400
- Independent pharmacies: $300 to $370
- Online and mail-order pharmacies: $250 to $340
At this price range, one inhaler per month translates to $3,000 to $4,800 per year without any coverage or assistance. The cost variation between pharmacies — sometimes exceeding $100 for the same product — makes price shopping essential for cash-paying patients. AstraZeneca, the manufacturer, sets the list price, but actual pharmacy charges reflect markup, distribution costs, and local market factors.
Airsupra Cost With Insurance
Insurance coverage for Airsupra is expanding as more plans add it to their formularies, but it remains inconsistent across payers.
Commercial Insurance
- Preferred brand tier: Copays of $25 to $60 per inhaler
- Non-preferred brand tier: $75 to $150 per inhaler
- Specialty tier or not covered: Full cost applies until formulary changes are made
Many commercial plans still consider Airsupra a non-preferred brand because generic albuterol inhalers and separate ICS (inhaled corticosteroid) inhalers are available at lower cost. Prior authorization frequently requires documentation that the combination approach is medically necessary — for example, evidence that the patient isn’t using their maintenance inhaler consistently or has had asthma exacerbations despite conventional therapy.
Medicare Part D
Coverage under Medicare Part D varies by plan. Patients who reach the $2,000 annual out-of-pocket cap pay nothing further for covered medications that year. However, the Inflation Reduction Act’s inhaler-specific provisions have also put pressure on manufacturers to keep inhaler costs under $35 per month for many patients — check with your specific plan for current Airsupra coverage terms.
Medicaid
Medicaid coverage varies by state. Some state programs have added Airsupra to preferred formularies, while others require step therapy through separate albuterol and ICS inhalers first. For an overview of prescription costs, see our healthcare costs guide.
AstraZeneca Savings Program
AstraZeneca offers a copay savings program for Airsupra that can significantly reduce out-of-pocket costs:
- Eligible commercially insured patients may pay as little as $0 to $35 per inhaler
- The program covers the difference between your copay and the savings threshold
- Not available to Medicare, Medicaid, Tricare, or other government-insured patients
- Enrollment through the Airsupra website or your prescriber’s office
This savings card is the single most effective way to reduce your Airsupra inhaler cost if you have commercial insurance. Activate it before picking up your first prescription — pharmacies can apply the card at the point of sale.
How to Save Money on Airsupra
Prescription Discount Cards
GoodRx, RxSaver, and SingleCare may offer modest discounts on Airsupra for cash-paying customers. Savings typically range from 5-15% off the retail price. While this won’t make the inhaler cheap, it can save $30-$60 per fill at participating pharmacies.
Patient Assistance Program
AstraZeneca’s patient assistance program provides free medications to eligible uninsured or underinsured patients. Income thresholds typically fall below 400% of the federal poverty level. The application requires proof of income, insurance status, and a prescriber’s signature. Processing takes two to four weeks.
Compare Pharmacy Prices
Price differences of $50-$100 between pharmacies in the same metro area are common for Airsupra. Use online price comparison tools before each fill. Specialty online pharmacies and certain warehouse clubs (Costco, Sam’s Club) sometimes offer lower pricing on brand-name inhalers.
FSA and HSA Accounts
Airsupra qualifies as an FSA/HSA-eligible expense. Using pre-tax dollars effectively provides a discount equal to your marginal tax rate. For a patient in the 24% tax bracket paying $300 per inhaler, that’s a real savings of $72 per fill.
Ask About Alternative Approaches
If cost is prohibitive, discuss alternatives with your doctor. Using a generic albuterol rescue inhaler plus a separate low-dose ICS maintenance inhaler can achieve similar anti-inflammatory rescue coverage at a fraction of the cost. The convenience and compliance benefits of Airsupra’s single-inhaler approach need to be weighed against the cost difference for your specific situation.
Why Airsupra Costs More Than Generic Albuterol
Generic albuterol (ProAir, Ventolin generics) costs roughly $20 to $50 per inhaler without insurance. Airsupra costs 5 to 10 times more. The price difference reflects several factors:
- Combination formulation: Airsupra combines albuterol with budesonide in a novel delivery system
- Patent protection: No generic or equivalent combination inhaler exists
- Clinical trial investment: AstraZeneca invested in large-scale trials (including the MANDALA study) demonstrating reduced exacerbation risk
- Manufacturing complexity: Combining two active ingredients in a metered-dose inhaler requires specialized production
According to research published in the New England Journal of Medicine, as-needed use of albuterol-budesonide reduced the risk of severe asthma exacerbations by 27% compared to albuterol alone. For patients with frequent exacerbations, this clinical benefit may justify the higher cost. The FDA approved Airsupra based on this evidence for patients aged 18 and older with asthma.
Factors That Determine Your Final Cost
- Insurance coverage and tier: The biggest variable in what you’ll pay
- Manufacturer savings card: Reduces commercially insured patients’ costs to $0-$35
- Pharmacy choice: Price differences of $50-$100 are common
- Usage frequency: Patients using Airsupra only occasionally will go through fewer inhalers annually
- Deductible status: Costs are higher before you meet your annual deductible
- Geographic location: Pharmacy pricing varies regionally
For pricing on other newer medications, see our guides on Nurtec costs and Journavx pricing.
Frequently Asked Questions
Is there a generic version of Airsupra?
No. As of 2026, no generic version of the albuterol/budesonide combination inhaler exists. AstraZeneca holds the patent, and no generic applications have been approved. Until generic competition arrives, prices will remain at brand-name levels.
Does insurance usually cover Airsupra?
Coverage is growing but not universal. Many commercial plans cover Airsupra with prior authorization, though some require step therapy (trying separate inhalers first). Medicare Part D coverage varies by plan. Check your plan’s formulary or call the number on your insurance card to verify coverage before filling the prescription.
How long does one Airsupra inhaler last?
Each Airsupra inhaler contains approximately 180 metered doses. How long it lasts depends on your usage pattern. For as-needed rescue use only, one inhaler may last several months. If used more frequently for both rescue and symptom management, you may need a new inhaler every one to two months.
Is Airsupra covered under the $35 inhaler cap?
The Inflation Reduction Act prompted several inhaler manufacturers to cap costs at $35 per month for certain patients. AstraZeneca has participated in similar initiatives for some of its products. Check with your plan and the manufacturer’s savings program for current terms, as these programs are subject to change.
Bottom Line on Airsupra Inhaler Cost
The Airsupra inhaler cost of $250 to $400 without insurance puts it in premium territory for a rescue inhaler. The clinical innovation — built-in anti-inflammatory protection with every rescue puff — adds genuine value for patients with poorly controlled asthma. With the manufacturer savings card, most commercially insured patients can access it for $35 or less per fill. Uninsured patients should explore the patient assistance program, and all patients should compare pharmacy prices and consider FSA/HSA accounts to offset costs. The gap between list price and what you actually pay can be enormous — but only if you take the steps to close it.